Skip to main content
    O

    Oncology Institute Inc (TOI)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ

    $5.13
    +0.27 (+5.56%)

    Market Cap: $512.91M

    Last updated: Aug 03, 2026 at 7:34 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    27%(4/15)
    Avg Surprise
    -49.67%
    Streak
    2 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.04
    Range$-0.06 - $0.00
    5 analysts
    EPS RevisionsNo revisions (7d)
    2
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.05+31.4%
    60d ago$-0.04+4.0%
    30d ago$-0.04+20.0%
    7d ago$-0.04+20.0%
    Current$-0.04
    Revenue Consensus
    $171M
    Range$166M - $178M
    5 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.05
    Range$0.01 - $0.10
    5 analysts
    Revenue Consensus
    $187M
    Range$172M - $208M
    5 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.05---
    Sep 26EST
    		-$-0.04---
    Jun 26
    Reported Aug 6
    		$N/A$-0.07N/ABeat-
    Mar 26
    Reported May 7
    		$-0.02N/A+77.78%Beat+90.4%
    Dec 25
    Reported Mar 12
    		$-0.06$-0.09+29.67%Beat+55.7%
    Sep 25
    Reported Nov 13
    		$-0.14$-0.11-27.27%Miss+20.0%
    Jun 25
    Reported Aug 13
    		$-0.15$-0.12-25.00%Miss-7.1%
    Mar 25
    Reported May 14
    		$-0.21$0.00N/ABeat-9.7%
    Dec 24
    Reported Mar 24
    		$-0.14$-0.08-78.75%Miss+31.9%
    Sep 24
    Reported Nov 13
    		$-0.18$-0.06-191.83%Miss-391.8%
    Jun 24
    Reported Aug 13
    		$-0.14$-0.10-40.00%Miss+26.3%
    Mar 24
    Reported May 14
    		$-0.19$-0.12-58.33%Miss+42.4%
    Dec 23
    Reported Mar 27
    		$-0.21$-0.11-90.91%Miss+4.5%
    Sep 23
    Reported Nov 8
    		$0.06N/A+146.15%Beat+106.8%
    Jun 23
    Reported Aug 8
    		$-0.19$-0.17-11.76%Miss-111.1%
    Mar 23
    Reported May 10
    		$-0.33$-0.17-94.12%Miss-232.0%
    Dec 22
    Reported Mar 9
    		$-0.22$-0.20-10.00%Miss-57.1%
    Sep 22
    Reported Nov 9
    		$-0.88$-0.18-388.89%Miss-4300.0%
    Jun 22
    Reported Aug 9
    		$-0.09$-0.11+18.18%Beat+57.1%
    Mar 22
    Reported May 11
    		$0.25N/AN/ABeat+25.0%
    Dec 21
    Reported Mar 10
    		$-0.14N/AN/ABeat-1300.0%
    Sep 21
    Reported Nov 8
    		$-0.02N/AN/ABeat-316.7%
    Jun 21
    Reported Aug 16
    		$-0.21N/AN/ABeat-5150.0%
    Mar 21
    Reported May 28
    		$0.20N/AN/ABeat-
    Dec 20
    Reported Mar 30
    		$-0.01N/AN/ABeat-
    Sep 20
    Reported Nov 13
    		$-0.00N/AN/ABeat-
    Jun 20
    Reported Aug 13
    		$-0.00N/AN/ABeat-
    Mar 20
    Reported May 8
    		$0.00$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin-7.97%Operating Margin-4.42%
    ROE-652.00%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current RatioN/AQuick RatioN/A
    Trading Statistics
    Beta0.42Avg VolumeN/A
    52-Week High$6.6752-Week Low$2.32

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$5.07
    SMA 20$5.41
    SMA 50$5.16
    SMA 200$3.86
    EMA 10$5.10
    EMA 20$5.21
    EMA 50$5.02
    EMA 200$4.04

    MACD

    Line: -0.08Signal: 0.00Hist: -0.08

    ADX

    ADX: 18.0+DI: 19.4-DI: 20.3

    Aroon & PSAR

    Aroon Up44.0
    Aroon Down84.0
    PSAR$5.44

    Bollinger Bands

    Upper Band$6.29
    Lower Band$4.53
    %B Position3251%(Upper)
    Band Width0.34

    RSI (14-Day)

    Neutral
    48.5

    Momentum Oscillators

    Stoch %K17.9
    Stoch %D13.2
    Williams %R-73.3
    ROC (10d)-6.7%
    Momentum-0.37
    CCI (20d)-72.1
    MFI (14d)22.5

    Volatility Measures

    ATR (14d)$0.38(7.3%)
    StdDev (20d)0.44
    Hist Vol75.3%(High)

    Volume Flow

    VWAP$5.05
    OBV51.4M
    AD Line-8.9M
    CMF (20d)-0.013

    Volume Metrics

    Avg Vol (20d)1.9M
    Vol Ratio0.7x
    VWMA (20d)$5.55

    Pivot Points

    R3$5.51
    R2$5.38
    R1$5.12
    Pivot Point$4.99
    S1$4.73
    S2$4.60
    S3$4.34

    Advanced Oscillators

    TSI-5.44
    Ultimate Osc42.8
    KST-15.28

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$161.28M$147.44M$141.96M$136.56M$119.80M$104.41M$100.27M$99.90M$98.58M$94.67M$85.79M$82.03M
    Cost of RevenueN/A$125.74M$119.19M$117.64M$102.30M$87.16M$85.63M$85.53M$85.55M$82.70M$71.41M$66.06M
    Gross ProfitN/A$21.70M$22.77M$18.92M$17.50M$17.25M$14.64M$14.37M$13.03M$11.97M$14.38M$15.98M
    Operating Expenses$165.89M$153.79M$148.91M$144.77M$131.07M$114.36M$112.15M$113.73M$114.39M$112.64M$99.83M$96.14M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$0$0$0$0$0$0$0$0$0$0$0$0
    Operating IncomeN/A$-6,513,000$-6,907,000$-8,054,000$-11,211,000$-9,911,000$-11,929,000$-13,853,000$-16,364,000$-17,972,000$-15,288,000$-13,925,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$0$1.92M$0$0$0$1.17M$0$0$0$1.94M$0
    Income Before Tax$-9,789,000$-2,492,000$-7,508,000$-16,504,000$-17,140,000$-19,585,000$-13,182,000$-16,113,000$-15,479,000$-19,889,000$-19,068,000$-17,284,000
    Income Tax Expense$0$0$0$0$-131,000$0$0$0$0$0$-314,000$135,000
    Net Income$-9,789,000$-2,492,000$-7,508,000$-16,504,000$-17,009,000$-19,585,000$-13,182,000$-16,113,000$-15,479,000$-19,889,000$-18,754,000$-17,419,000
    EBITDA$-1,516,000$-3,518,000$-4,114,000$-5,309,000$-8,330,000$-3,296,000$-8,582,000$-10,721,000$-12,856,000$-15,248,000$-12,813,000$-9,964,000
    EBIT$-4,610,000$-6,345,000$-6,951,000$-8,204,000$-11,264,000$-9,954,000$-11,882,000$-13,833,000$-15,812,000$-17,972,000$-14,043,000$-14,105,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about TOI

    News

    The Oncology Institute, Inc. (STLN) Income Statement

    The article provides the income statement for The Oncology Institute, Inc. (STLN) showing financial data for annual and quarterly periods up to 2025-12-31...

    Yahoo! Finance Canada•8/7/26•Neutral

    The Oncology Institute, Inc. $TOI Shares Bought by Arrowstreet Capital Limited Partnership

    Arrowstreet Capital Limited Partnership significantly increased its stake in The Oncology Institute, Inc. ($TOI) by 169.3% in the first quarter...

    MarketBeat•8/7/26•Somewhat-Bullish

    Oncology Institute Q2 Earnings Call Highlights

    Oncology Institute reported strong Q2 revenue growth, positive adjusted EBITDA, and rebranded as Starling Oncology to reflect its evolution into a national value-based oncology provider. The company expanded its...

    TradingView•8/7/26•Bullish

    Form 8K Oncology Institute Inc For: 6 August By Investing.com

    The article reports on an 8K filing by Oncology Institute Inc. for August 6. It includes a stock market publication timestamp and references the company's stock symbol STLN. The content also features various market data...

    Investing.com Canada•8/6/26•Neutral

    The Oncology Institute, Inc. Revenue Breakdown – NASDAQ:STLN

    The Oncology Institute, Inc. (NASDAQ: STLN) generated $502.73 million in revenue last year, with its Dispensary segment being the top performer, contributing $269.18 million. The majority of its revenue, $502.73 million...

    TradingView•8/5/26•Neutral

    TOI Profitability: Margins, ROIC and FCF

    Operating margin
    -4.4%
    Net margin
    -8.0%
    ROE
    -652.0%

    TOI Competitors

    CompanyTicker
    Evolent Health IncEVH
    Delcath Systems IncDCTH
    Puma Biotechnology IncPBYI
    CytomX Therapeutics IncCTMX
    Shattuck Labs IncSTTK
    Tactile Systems Technology IncTCMD
    Bright Minds Biosciences IncDRUG
    Evolus IncEOLS

    Sector: Healthcare

    TOI Analyst Ratings

    Consensus
    Buy
    Analysts
    5
    Strong Buy
    1
    Buy
    4
    Hold
    0
    Sell
    0
    Strong Sell
    0

    TOI Bull Case vs Bear Case

    Bull case

    • TOI grew quarterly revenue 41.2% year over year.
    • 100.0% of TOI's analyst ratings are Buy or Strong Buy.

    Bear case

    • TOI has a -8.0% net profit margin.
    • TOI beat EPS estimates in 25.0% of its last 8 reported quarters.

    TOI Earnings: Beat Rate and Next Report

    Beat rate
    2 of 8 quarters (25.0%)
    Average surprise
    -36.5%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.04
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    2 up, 1 down

    Frequently Asked Questions About TOI

    Does TOI pay dividends?

    Oncology Institute Inc (TOI) does not currently pay a regular dividend.

    What is TOI's market cap?

    Oncology Institute Inc (TOI) has a market capitalization of $512.91M with a current stock price of $5.13.

    Related stocks

    Sector: Healthcare

    All stocks starting with T

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In